Myeloid Malignancies
📧 Sign up to get email alerts when something new happens for Myeloid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies [Phase 1, Phase 2]
ExCellThera's US trial of ECT-001-CB in pediatric and young adult patients with high-risk myeloid malignancies (cord blood transplant) has c…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies [Phase 1]
A Phase 1 trial evaluating CC-486/Onureg in participants with hepatic impairment versus normal hepatic function in myeloid malignancies has …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. [Phase 2]
Phase 2 pediatric trial evaluating GVHD prophylaxis without calcineurin inhibitors after day 60 post first allogeneic hematopoietic stem cel…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Study of Magrolimab Combinations in Participants With Myeloid Malignancies [Phase 2]
Phase 2 study evaluating magrolimab combinations in participants with myeloid malignancies was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT [Phase 2]
Phase 2 trial update on natural killer (NK) cell-enriched dendritic cell vaccines with or without a RLR9 agonist (DUK-CPG-001) from donors a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies [Phase 2]
Phase 2 trial update on fractionated busulfan conditioning before allogeneic stem cell transplantation in myeloid malignancies.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update assessing post-transplant high-dose cyclosporine as GvHD prophylaxis in 1 HLA-mismatched unrelated hematopoiet…
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis [Phase 2]
Phase 2 trial of imetelstat sodium in adults with primary or secondary myelofibrosis has completed enrollment and results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT [Phase 2, Phase 3]
Phase 2/3 trial evaluating decitabine in combination with a BUCY conditioning regimen versus BUCY alone for TP53+ myeloid tumors undergoing …
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]
Clinical trial update for a CD33-targeted CAR-T therapy in myeloid malignancies (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]
Clinical trial update for LeY-targeted CAR-T in myeloid malignancies currently in Phase 1/Phase 2.